as of 09-03-2026 3:51pm EST
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | 2026 |
| Target Price: | N/A | AVG Volume (30 days): | 244.1K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $15.25 - $20.61 | Next Earning Date: | N/A |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
Director, 10% Owner
Avg Cost/Share
$16.00
Shares
312,500
Total Value
$5,000,000.00
Owned After
3,614,034
SEC Form 4
Director
Avg Cost/Share
$16.00
Shares
6,000
Total Value
$96,000.00
Owned After
6,000
SEC Form 4
Director
Avg Cost/Share
$16.00
Shares
625,000
Total Value
$10,000,000.00
Owned After
2,714,279
SEC Form 4
Director
Avg Cost/Share
$16.00
Shares
625,000
Total Value
$10,000,000.00
Owned After
2,714,279
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$16.00
Shares
700
Total Value
$11,200.00
Owned After
700
SEC Form 4
General Counsel
Avg Cost/Share
$16.00
Shares
2,200
Total Value
$35,200.00
Owned After
111,412
SEC Form 4
General Counsel
Avg Cost/Share
$15.80
Shares
2,500
Total Value
$39,500.00
Owned After
111,412
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Chen Bihua | BLSM | Director, 10% Owner | Aug 10, 2026 | Buy | $16.00 | 312,500 | $5,000,000.00 | 3,614,034 | |
| Schmid John P. | BLSM | Director | Aug 10, 2026 | Buy | $16.00 | 6,000 | $96,000.00 | 6,000 | |
| ORBIMED ADVISORS LLC | BLSM | Director | Aug 10, 2026 | Buy | $16.00 | 625,000 | $10,000,000.00 | 2,714,279 | |
| GORDON CARL L | BLSM | Director | Aug 10, 2026 | Buy | $16.00 | 625,000 | $10,000,000.00 | 2,714,279 | |
| Keyes Jason A | BLSM | Chief Financial Officer | Aug 10, 2026 | Buy | $16.00 | 700 | $11,200.00 | 700 | |
| Liptak Vincent Paul | BLSM | General Counsel | Aug 10, 2026 | Buy | $16.00 | 2,200 | $35,200.00 | 111,412 | |
| Liptak Vincent Paul | BLSM | General Counsel | Aug 7, 2026 | Buy | $15.80 | 2,500 | $39,500.00 | 111,412 |
See how BLSM stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "BLSM BlossomHill Therapeutics Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.